These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11807228)

  • 1. Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain.
    Girn J; Kavoosi M; Chantler J
    J Gen Virol; 2002 Feb; 83(Pt 2):351-358. PubMed ID: 11807228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary heterotypic versus homotypic infection by Coxsackie B group viruses: impact on early and late histopathological lesions and virus genome prominence.
    Yu JZ; Wilson JE; Wood SM; Kandolf R; Klingel K; Yang D; McManus BM
    Cardiovasc Pathol; 1999; 8(2):93-102. PubMed ID: 10724506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxsackievirus B3 induces apoptosis in the early phase of murine myocarditis: a comparative analysis of cardiovirulent and noncardiovirulent strains.
    Joo CH; Hong HN; Kim EO; Im JO; Yoon SY; Ye JS; Moon MS; Kim D; Lee H; Kim YK
    Intervirology; 2003; 46(3):135-40. PubMed ID: 12867750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coxsackievirus B3-induced myocarditis: differences in the immune response of C57BL/6 and Balb/c mice.
    Leipner C; Grün K; Schneider I; Glück B; Sigusch HH; Stelzner A
    Med Microbiol Immunol; 2004 May; 193(2-3):141-7. PubMed ID: 14593475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand.
    Huber S; Shi C; Budd RC
    J Virol; 2002 Jul; 76(13):6487-94. PubMed ID: 12050361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis.
    Kishimoto C; Kurokawa M; Ochiai H
    J Mol Cell Cardiol; 2002 Sep; 34(9):1227-38. PubMed ID: 12392896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice.
    Tracy S; Höfling K; Pirruccello S; Lane PH; Reyna SM; Gauntt CJ
    J Med Virol; 2000 Sep; 62(1):70-81. PubMed ID: 10935991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection.
    Jrad-Battikh N; Souii A; Oueslati L; Aouni M; Hober D; Gharbi J; Ben M'hadheb-Gharbi M
    Curr Microbiol; 2014 Apr; 68(4):503-9. PubMed ID: 24322405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The group B coxsackieviruses and myocarditis.
    Kim KS; Hufnagel G; Chapman NM; Tracy S
    Rev Med Virol; 2001; 11(6):355-68. PubMed ID: 11746998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects.
    Beck MA; Chapman NM; McManus BM; Mullican JC; Tracy S
    Am J Pathol; 1990 Mar; 136(3):669-81. PubMed ID: 2156432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.
    Gauntt CJ; Arizpe HM; Higdon AL; Wood HJ; Bowers DF; Rozek MM; Crawley R
    J Immunol; 1995 Mar; 154(6):2983-95. PubMed ID: 7533190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets interact with Coxsackieviruses B and have a critical role in the pathogenesis of virus-induced myocarditis.
    Negrotto S; Jaquenod de Giusti C; Rivadeneyra L; Ure AE; Mena HA; Schattner M; Gomez RM
    J Thromb Haemost; 2015 Feb; 13(2):271-82. PubMed ID: 25393316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterovirus-infected immune cells of spleen and lymph nodes in the murine model of chronic myocarditis: a role in pathogenesis?
    Klingel K; McManus BM; Kandolf R
    Eur Heart J; 1995 Dec; 16 Suppl O():42-5. PubMed ID: 8682099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation.
    Fan Y; Weifeng W; Yuluan Y; Qing K; Yu P; Yanlan H
    Virol J; 2011 Jan; 8():17. PubMed ID: 21235788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes.
    Jarasch-Althof N; Wiesener N; Schmidtke M; Wutzler P; Henke A
    Viral Immunol; 2010 Aug; 23(4):369-76. PubMed ID: 20712481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.
    Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y
    Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans.
    Lim BK; Ju ES; Lao DH; Yun SH; Lee YJ; Kim DK; Jeon ES
    Microbiol Immunol; 2013 Apr; 57(4):281-7. PubMed ID: 23586632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-cardiovirulent strain of coxsackievirus B3 causes myocarditis in mice with severe combined immunodeficiency syndrome.
    Hufnagel G; Chapman N; Tracy S
    Eur Heart J; 1995 Dec; 16 Suppl O():18-9. PubMed ID: 8682092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmissible endoplasmic reticulum stress from myocardiocytes to macrophages is pivotal for the pathogenesis of CVB3-induced viral myocarditis.
    Zhang H; Yue Y; Sun T; Wu X; Xiong S
    Sci Rep; 2017 Feb; 7():42162. PubMed ID: 28176833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.